从全球图书识别和可视化角度对糖尿病病中的生物标志物研究进行全面审查
Qin Li1, Yafei Xie2, Meiying Zuo2
1Hunan University of Medicine, Huaihua, China.
Medicine
|November 29, 2024
概括
这种图书统计分析可视化了糖尿病病 (DN) 生物标志物研究,识别了关键趋势和有前途的主题,如早期诊断和治疗的巨和奥米克. 它为未来的研究和资源分配提供了洞察力.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 生物标志物研究 生物标志物研究
背景情况:
- 糖尿病病 (DN) 是一种严重的糖尿病并发症,导致末期病.
- 早期诊断和治疗对于管理DN至关重要.
- 生物标志物对于DN诊断和治疗至关重要,引起了相当大的研究兴趣.
研究的目的:
- 想象在糖尿病病 (DN) 中生物标志物研究的领域,使用文献识别分析.
- 总结DN生物标志物研究的现状并预测未来的趋势.
- 为该领域的研究人员和政策制定者提供见解.
主要方法:
- 从科学网络核心集合 (1995-2023) 中对出版物的图书统计分析.
- 使用微软Excel,VOSviewer,Bibliometrix R包和CiteSpace.Space进行数据分析和可视化.
主要成果:
- 确定了1274篇关于DN生物标志物研究的出版物,显示出稳定的增长.
- 中国,斯泰诺糖尿病中心和内分泌学前沿是最具生产力的国家,机构和期刊.
- 关键词包括白膜尿,慢性病和表达;巨细胞,纤维化和奥米克显示潜力.
结论:
- 该研究提供了全球DN生物标志物研究的全面概述,突出其结构,热点和趋势.
- 这些发现可以从宏观角度指导未来的研究.
- 该分析作为资源分配和确定研究合作的基础.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
498
10:37Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
99
相关概念视频
Glucose Transporters
15.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
15.2K
Glucose Absorption Into the Small Intestine
34.0K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.0K
Diabetes: Symptoms, Diagnosis, and Complications
2.5K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.5K
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
17
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Hypoglycemia
30
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
30
Hyperglycemia
25
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose...
25
